Effectiveness and safety of dual antiplatelet therapy in patients with minor ischemic stroke or transient ischemic attack and cancer: A secondary analysis of the READAPT study
Year: 2025
Type: article
Abstract: Introduction: Patients with ischemic stroke or transient ischemic attack (TIA) and cancer face unique risks of recurrent ischemic events and bleeding. It is unclear whether this increased risk is present even in patients with minor ischemic stroke or transient ischemic attack (TIA) receiving dual antiplatelet therapy (DAPT). This study aimed to evaluate the impact of cancer on the short-term outcomes after DAPT in patients with non-cardioembolic minor ischemic stroke or high-risk TIA. Patients and methods: This was a secondary analysis of the prospective multicentric READAPT study (NCT05476081), including patients with non-cardioembolic minor ischemic stroke (NIHSS ⩽ 5) or high-risk TIA (ABCD2 ⩾4) who initiated DAPT within 48 h of symptom onset. The primary effectiveness outcome was the 90-day risk of new ischemic stroke or other vascular events (TIA, myocardial infarction, death due to vascular causes). Secondary outcomes included 90-day mRS score distribution and all-cause mortality. The primary safety outcome was the 90-day risk of any bleeding, with secondary safety outcomes including 24-h hemorrhagic transformation. We used Inverse Probability Weighting to compare outcomes between patients with and without cancer. Results: From 2278 patients in the READAPT study cohort, we included 1561 patients (mean age 70.3 ± 11.7 years; 65.4% males), of whom 206 (13.2%) had cancer, categorized as either active (27.7%) or in remission (72.3%). After weighting, overall cancer patients had a higher risk of 90-day new ischemic stroke or other vascular events (weighted HR 1.78, 95% CI 1.20–2.63, p = 0.004) and worse 90-day mRS score distribution (OR 1.24, 95% CI 1.10–1.41, p < 0.001) compared to patients without cancer. The 90-day risk of bleeding did not differ between cancer and no-cancer groups overall. When analyzing cancer subgroups, patients with active cancer had significantly higher risk of 90-day ischemic stroke or other vascular (weighted HR 2.75, 95% CI 1.70–4.45, p < 0.001) and any bleeding (weighted HR 2.51, 95% CI 1.27–4.97, p = 0.008) events compared to no-cancer patients. In contrast, patients with cancer in remission had comparable risks to those without cancer. Furthermore, hematological malignancies were associated with a substantially higher risk of 90-day new ischemic stroke or other vascular events compared to solid tumors (weighted HR 8.15, 95% CI 5.06–13.14, p < 0.001). Conclusions: Patients with minor ischemic stroke or high-risk TIA and active cancer have increased risk of ischemic and bleeding events after DAPT. Conversely, patients with cancer in remission have similar outcomes compared to those with no cancer.
Source: European Stroke Journal
Authors: Matteo Foschi, Federico De Santis, Lucio D’Anna, Michele Romoli, Tiziana Tassinari, Valentina Saia, Silvia Cenciarelli, Chiara Bedetti, Chiara Padiglioni, Bruno Censori, Valentina Puglisi, Luisa Vinciguerra, Maria Guarino, Valentina Barone, Marialuisa Zedde, Ilaria Grisendi, Marina Diomedi, Maria Rosaria Bagnato, Marco Petruzzellis, Domenico Maria Mezzapesa, Vincenzo Inchingolo, Manuel Cappellari, Cecilia Zivelonghi, Paolo Candelaresi, Vincenzo Andreone, Giuseppe Rinaldi, Alessandra Bavaro, Anna Maria Cavallini, Maria Grazia Piscaglia, Valeria Terruso, Marina Mannino, Alessandro Pezzini, Giovanni Frisullo, Francesco Muscia, Maurizio Paciaroni, Maria Giulia Mosconi, Andrea Zini, Ruggiero Leone, Carmela Palmieri, Letizia Maria Cupini, Michela Marcon, Rossana Tassi, Enzo Sanzaro, Giulio Papiri, Giovanna Viticchi, Daniele Orsucci, Anne Falcou, Susanna Diamanti, Roberto Tarletti, Patrizia Nencini, Eugenia Rota, Federica Nicoletta Sepe, Delfina Ferrandi, Luigi Caputi, Gino Volpi, Salvatore Laspada, Mario Beccia, Claudia Rinaldi, Vincenzo Mastrangelo, Francesco Di Blasio, Paolo Invernizzi, Giuseppe Pelliccioni, Maria Vittoria De Angelis, Laura Bonanni, Giampietro Ruzza, Emanuele Alessandro Caggia, Monia Russo, Agnese Tonon, Maria Cristina Acciarri, Sabrina Anticoli, Cinzia Roberti, Giovanni Manobianca, Gaspare Scaglione, Francesca Pistoia, Alberto Fortini, Antonella De Boni, Alessandra Sanna, Alberto Chiti, Marcella Caggiula, Maela Masato, Massimo Del Sette, Francesco Passarelli, Maria Roberta Bongioanni, Manuela De Michele, Stefano Ricci, Eleonora De Matteis, Raffaele Ornello, Simona Sacco, on behalf of the READAPT Study Group
Institutions: University of L'Aquila, Imperial College Healthcare NHS Trust, Charing Cross Hospital, Imperial College London, Ospedale “M. Bufalini” di Cesena, Ospedale Santa Corona, Città di Castello Hospital, Azienda Ospedaliera Ospedale Maggiore, Istituto delle Scienze Neurologiche di Bologna, Azienda Sanitaria Unità Locale di Reggio Emilia, University of Rome Tor Vergata, Azienda Universitaria Ospedaliera Consorziale - Policlinico Bari, Casa Sollievo della Sofferenza, Azienda Ospedaliera Universitaria Integrata Verona, Ospedale Antonio Cardarelli, Fondazione Istituto Neurologico Nazionale Casimiro Mondino, Ospedale "Santa Maria delle Croci" di Ravenna, Ospedale Vincenzo Cervello, University of Parma, Agostino Gemelli University Polyclinic, Aziende Socio Sanitarie Territoriale Ovest Milanese, University of Ferrara, Azienda Ospedaliera di Perugia, Ospedale Maggiore Carlo Alberto Pizzardi, Ospedale Civile Edoardo Agnelli, St. Eugenio Hospital, Azienda Ospedaliera Universitaria Senese, Marche Polytechnic University, Policlinico Umberto I, Azienda Ospedaliero Universitaria Maggiore della Carita, Azienda Ospedaliero-Universitaria Careggi, Azienda Ospedaliera Nazionale SS. Antonio e Biagio e Cesare Arrigo, Ospedale A. Perrino, Azienda Ospedaliera Sant'Andrea, Ospedale Infermi di Rimini, Fondazione Poliambulanza Istituto Ospedaliero, Istituto Nazionale di Riposo e Cura per Anziani, Ospedale SS. Annunziata, University of Chieti-Pescara, Ospedale Santa Maria della Misericordia di Rovigo, Ospedale Civile di Venezia, Azienda Ospedaliera San Camillo-Forlanini, Ospedale San Filippo Neri, Ospedale Generale Regionale Francesco Miulli, Nuovo Ospedale San Giovanni di Dio, Ospedale San Bortolo, Azienda Ospedaliero Universitaria di Sassari, Ospedale Vito Fazzi, Ospedale di Mirano, Ospedale Policlinico San Martino, Fatebenefratelli Hospital, Ospedale San Pietro Fatebenefratelli, Sapienza University of Rome
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4409703535